Literature DB >> 25088150

Citrobacter rodentium: infection, inflammation and the microbiota.

James W Collins1, Kristie M Keeney2, Valerie F Crepin1, Vijay A K Rathinam3, Katherine A Fitzgerald3, B Brett Finlay2, Gad Frankel1.   

Abstract

Citrobacter rodentium is a mucosal pathogen of mice that shares several pathogenic mechanisms with enteropathogenic Escherichia coli (EPEC) and enterohaemorrhagic E. coli (EHEC), which are two clinically important human gastrointestinal pathogens. Thus, C. rodentium has long been used as a model to understand the molecular basis of EPEC and EHEC infection in vivo. In this Review, we discuss recent studies in which C. rodentium has been used to study mucosal immunology, including the deregulation of intestinal inflammatory responses during bacteria-induced colitis and the role of the intestinal microbiota in mediating resistance to colonization by enteric pathogens. These insights should help to elucidate the roles of mucosal inflammatory responses and the microbiota in the virulence of enteric pathogens.

Entities:  

Mesh:

Year:  2014        PMID: 25088150     DOI: 10.1038/nrmicro3315

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  123 in total

1.  Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.

Authors:  Myung H Kim; Seung G Kang; Jeong H Park; Masashi Yanagisawa; Chang H Kim
Journal:  Gastroenterology       Date:  2013-05-07       Impact factor: 22.682

2.  Epithelial phosphatidylinositol-3-kinase signaling is required for β-catenin activation and host defense against Citrobacter rodentium infection.

Authors:  Jeffrey B Brown; Paul Cheresh; Tatiana Goretsky; Elizabeth Managlia; Gery R Grimm; Hyunji Ryu; Mojgan Zadeh; Ramanarao Dirisina; Terrence A Barrett
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

3.  Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis.

Authors:  M Wlodarska; B Willing; K M Keeney; A Menendez; K S Bergstrom; N Gill; S L Russell; B A Vallance; B B Finlay
Journal:  Infect Immun       Date:  2011-02-14       Impact factor: 3.441

4.  Novel changes in NF-{kappa}B activity during progression and regression phases of hyperplasia: role of MEK, ERK, and p38.

Authors:  Parthasarathy Chandrakesan; Ishfaq Ahmed; Tariq Anwar; Yu Wang; Shubhashish Sarkar; Pomila Singh; Sara Peleg; Shahid Umar
Journal:  J Biol Chem       Date:  2010-08-14       Impact factor: 5.157

5.  Development of fatal colitis in FVB mice infected with Citrobacter rodentium.

Authors:  Diana Borenshtein; Prashant R Nambiar; Elizabeth B Groff; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

6.  Quorum sensing has an unexpected role in virulence in the model pathogen Citrobacter rodentium.

Authors:  Sarah J Coulthurst; Simon Clare; Terry J Evans; Ian J Foulds; Kevin J Roberts; Martin Welch; Gordon Dougan; George P C Salmond
Journal:  EMBO Rep       Date:  2007-06-08       Impact factor: 8.807

7.  Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection.

Authors:  Rosanna Mundy; Liljana Petrovska; Katherine Smollett; Nandi Simpson; Rebecca K Wilson; Jun Yu; Xuanlin Tu; Ilan Rosenshine; Simon Clare; Gordon Dougan; Gad Frankel
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

Review 8.  Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal.

Authors:  Gad Frankel; Alan D Phillips
Journal:  Cell Microbiol       Date:  2007-12-04       Impact factor: 3.715

9.  Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells.

Authors:  E L Hartland; M Batchelor; R M Delahay; C Hale; S Matthews; G Dougan; S Knutton; I Connerton; G Frankel
Journal:  Mol Microbiol       Date:  1999-04       Impact factor: 3.501

10.  Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-β (TRIF)-mediated caspase-11 protease production integrates Toll-like receptor 4 (TLR4) protein- and Nlrp3 inflammasome-mediated host defense against enteropathogens.

Authors:  Prajwal Gurung; R K Subbarao Malireddi; Paras K Anand; Dieter Demon; Lieselotte Vande Walle; Zhiping Liu; Peter Vogel; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  J Biol Chem       Date:  2012-08-16       Impact factor: 5.157

View more
  181 in total

1.  Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway.

Authors:  Shiyang Li; Jennifer J Heller; John W Bostick; Aileen Lee; Hilde Schjerven; Philippe Kastner; Susan Chan; Zongming E Chen; Liang Zhou
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

Review 2.  Pathogen control at the intestinal mucosa - H2O2 to the rescue.

Authors:  Ulla G Knaus; Rosanne Hertzberger; Gratiela G Pircalabioru; S Parsa M Yousefi; Filipe Branco Dos Santos
Journal:  Gut Microbes       Date:  2017-01-12

3.  Identification and regulation of a novel Citrobacter rodentium gut colonization fimbria (Gcf).

Authors:  Gustavo G Caballero-Flores; Matthew A Croxen; Verónica I Martínez-Santos; B Brett Finlay; José L Puente
Journal:  J Bacteriol       Date:  2015-02-09       Impact factor: 3.490

Review 4.  Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.

Authors:  D J Silberger; C L Zindl; C T Weaver
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

5.  Lactobacillus acidophilus counteracts inhibition of NHE3 and DRA expression and alleviates diarrheal phenotype in mice infected with Citrobacter rodentium.

Authors:  Anoop Kumar; Arivarasu N Anbazhagan; Hayley Coffing; Ishita Chatterjee; Shubha Priyamvada; Tarunmeet Gujral; Seema Saksena; Ravinder K Gill; Waddah A Alrefai; Alip Borthakur; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-15       Impact factor: 4.052

6.  Humoral Immunity in the Gut Selectively Targets Phenotypically Virulent Attaching-and-Effacing Bacteria for Intraluminal Elimination.

Authors:  Nobuhiko Kamada; Kei Sakamoto; Sang-Uk Seo; Melody Y Zeng; Yun-Gi Kim; Marilia Cascalho; Bruce A Vallance; José L Puente; Gabriel Núñez
Journal:  Cell Host Microbe       Date:  2015-04-30       Impact factor: 21.023

7.  Virulence factors enhance Citrobacter rodentium expansion through aerobic respiration.

Authors:  Christopher A Lopez; Brittany M Miller; Fabian Rivera-Chávez; Eric M Velazquez; Mariana X Byndloss; Alfredo Chávez-Arroyo; Kristen L Lokken; Renée M Tsolis; Sebastian E Winter; Andreas J Bäumler
Journal:  Science       Date:  2016-09-15       Impact factor: 47.728

8.  Aquaporin-3 mediates hydrogen peroxide-dependent responses to environmental stress in colonic epithelia.

Authors:  Jay R Thiagarajah; Jeffrey Chang; Jeremy A Goettel; Alan S Verkman; Wayne I Lencer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

9.  Opioid use potentiates the virulence of hospital-acquired infection, increases systemic bacterial dissemination and exacerbates gut dysbiosis in a murine model of Citrobacter rodentium infection.

Authors:  Fuyuan Wang; Jingjing Meng; Li Zhang; Sabita Roy
Journal:  Gut Microbes       Date:  2019-08-05

10.  Citrobacter rodentium Infection Inhibits Colonic P-glycoprotein Expression.

Authors:  Mitul Patel; Anoop Kumar; Dulari Jayawardena; Shubha Priyamvada; Arivarasu N Anbazhagan; Waddah A Alrefai; Ravinder K Gill; Pradeep K Dudeja; Seema Saksena
Journal:  Gene Rep       Date:  2019-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.